| 1. |
國家心血管病中心, 中國心血管健康與疾病報告編寫組. 中國心血管健康與疾病報告 2024 概要. 中國循環雜志, 2025, 40(6):521-559.
|
| 2. |
Muhs T, Ljubojevic-Holzer S, Sattler S. Anti-inflammatory therapies for ischemic heart disease. Curr Cardiol Rep, 2025, 27(1): 57.
|
| 3. |
宋學武. 基于機器學習的老年缺血性心臟病患者的預后研究. 成都: 電子科技大學, 2025.
|
| 4. |
Stone PH, Libby P, Boden WE. Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management—the plaque hypothesis:a narrative review. JAMA Cardiol, 2023, 8(2): 192-201.
|
| 5. |
Hou L, Shan S, Lu K, et al. Lactation duration and ischemic heart disease among parous postmenopausal females from a prospective cohort study. Commun Med (Lond), 2025, 5(1): 86.
|
| 6. |
練璐, 曹冬麗, 李思清, 等. 基于供需雙方視角的基本公共衛生服務項目效果評價. 中國公共衛生, 2024, 40(5): 550-555.
|
| 7. |
Wang Z, Zhu D, Zhang H, et al. Recommendations and quality of multimorbidity guidelines: a systematic review. Ageing Res Rev, 2024, 102: 102559.
|
| 8. |
鄭曉夢, 周旋, 孫雨, 等. 心血管代謝性共病患者的臨床特征及用藥特點研究. 中國全科醫學, 2025, 28(9): 1061-1064, 1071.
|
| 9. |
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440): 2133-2161.
|
| 10. |
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440): 2162-2203.
|
| 11. |
張強, 趙曉曉, 王海博, 等. 1990—2021 年全球與中國老年人群代謝功能障礙相關脂肪性肝病的疾病負擔分析. 醫學新知, 2026, 36(4): 428-437.
|
| 12. |
趙曉曉, 柯立鑫, 荀楊芹, 等. 1990—2021年全球與中國老年2型糖尿病的疾病負擔調查與未來趨勢預測. 中國全科醫學, 2025, 28(16): 2050-2058.
|
| 13. |
陳嘉慧, 王海博, 柯立鑫, 等. 1990 年—2021 年中國因非酒精性脂肪性肝炎所致肝癌的疾病負擔分析與未來趨勢預測研究. 華西醫學, 2025, 40(4): 546-553.
|
| 14. |
張越, 張英英, 丁玲, 等. 基于 Joinpoint 回歸及年齡-時期-隊列模型分析中國腎功能損傷所致心血管病死亡率變化趨勢. 中華疾病控制雜志, 2024, 28(7): 764-769, 783.
|
| 15. |
Deng X, Li H, Zhong Y, et al. Burden of liver cancer attributable to hepatitis B and alcohol globally, in China, and for five sociodemographic index regions from 1990 to 2021: a population-based study. J Clin Transl Hepatol, 2025, 13(1): 1-14.
|
| 16. |
Majidi M, Eslami V, Ghorbani P, et al. Are women more susceptible to ischemic heart disease compared to men? A literature overview. J Geriatr Cardiol, 2021, 18(4): 289-296.
|
| 17. |
張振香, 何福培, 張春慧, 等. 慢性病共病患者服藥依從性潛在類別及其影響因素分析. 中國全科醫學, 2022, 25(31): 3904-3913.
|
| 18. |
彭天嬌, 張韋, 朱成燕, 等. 央地視角下長期護理保險政策比較研究. 中國衛生政策研究, 2026, 19(1): 9-16.
|
| 19. |
Yan C, Xu Z, Huang W. Cellular senescence affects cardiac regeneration and repair in ischemic heart disease. Aging Dis, 2021, 12(2): 552-569.
|
| 20. |
Palmer AK, Jensen MD. Metabolic changes in aging humans: current evidence and therapeutic strategies. J Clin Invest, 2022, 132(16): e158451.
|
| 21. |
Alexeeff SE, Liao NS, Liu X, et al. Long-term PM2.5 exposure and risks of ischemic heart disease and stroke events: review and meta-analysis. J Am Heart Assoc, 2021, 10(1): e016890.
|
| 22. |
Eng A, Denison HJ, Corbin M, et al. Long working hours, sedentary work, noise, night shifts and risk of ischaemic heart disease. Heart, 2023, 109(5): 372-379.
|
| 23. |
Haile D, Harding KL, McLaughlin SA, et al. Health effects associated with consumption of processed meat, sugar-sweetened beverages and trans fatty acids: a burden of proof study. Nat Med, 2025, 31(7): 2244-2254.
|
| 24. |
Lu J, Zhang L, Lu Y, et al. Secondary prevention of cardiovascular disease in China. Heart, 2020, 106(17): 1349-1356.
|
| 25. |
Jauho M. The North Karelia Project (1972-1997) and the origins of the community approach to cardiovascular disease prevention. Am J Public Health, 2021, 111(5): 890-895.
|
| 26. |
Liu Q, Huang YJ, Zhao L, et al. Association between knowledge and risk for cardiovascular disease among older adults: a cross-sectional study in China. Int J Nurs Sci, 2020, 7(2): 184-190.
|
| 27. |
大氣污染健康防護專家共識編寫組. 降低大氣細顆粒物健康危害的綜合措施專家共識. 環境與職業醫學, 2025, 42(9): 1025-1037, 1053.
|
| 28. |
Xiao Y, Zhang J, Sun L, et al. Optical theranostics in ischemic heart disease: from molecular insights to clinical translation. Theranostics, 2025, 15(14): 6789-6817.
|
| 29. |
丁勝. 中醫活血化瘀法治療缺血性心臟病的臨床經驗研究. 內蒙古中醫藥, 2025, 44(8): 17-19.
|
| 30. |
中華醫學會心血管病學分會, 中華心血管病雜志編輯委員會. 經皮冠狀動脈介入治療指南(2025). 中華心血管病雜志, 2025, 53(7): 717-745.
|
| 31. |
劉玥, 高鑄燁, 付長庚, 等. 活血化瘀藥物防治冠心病: 循證與展望. 中國循證醫學雜志, 2018, 18(11): 1145-1150.
|
| 32. |
Yang Y, Li X, Chen G, et al. Traditional chinese medicine compound (tongxinluo) and clinical outcomes of patients with acute myocardial infarction: the CTS-AMI randomized clinical trial. JAMA, 2023, 330(16): 1534-1545.
|
| 33. |
中華醫學會心血管病學分會, 中華心血管病雜志編輯委員會. 缺血性心肌病血運重建專家共識. 中華心血管病雜志, 2025, 53(4): 343-355.
|
| 34. |
李嘉麗, 任春貞, 劉璠, 等. 1990—2021 年全球與中國≥60 歲人群高血壓性心臟病的疾病負擔分析. 中國胸心血管外科臨床雜志, 2026, 33(2): 281-290.
|